glp-1 news today september 2025 RA prescription trends: January 2018 – September 8, 2025: FDA launches
Description
Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.
Learn to address challenges associated with the use of GLP-1 medications in the treatment of obesity and earn 3.75 CEUs today!
Ingredients, research, pricing, MLM structure, and how it compares to prescription GLP-1 medications.
Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases
